Non Alcoholic Fatty Liver Clinical Trial
Official title:
Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.
assessment of NAFLD among diabetic, pre-diabetic and non diabetic participants Using Non Invasive Methods.And correlation between lab and radiological methods .
Non alcoholic fatty liver disease (NAFLD) is a major public health problem. with 10-30% prevalence worldwide , and is a common cause of chronic liver disease and the third most common cause of liver transplantation . NAFLD can range from simple steatosis in the absence of inflammation to nonalcoholic steatohepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC) . Major risk factors for NAFLD include obesity, hypertension , hyperlipidemia , hypertriglyceridemia , and type-2-diabetes mellitus (T2DM) . The gold standard in the diagnosis of NAFLD is liver biopsy; however, it is sometimes associated with some complications that include bleeding, bile leak, infection, and other potential life-threatening issues. The accuracy of the MRI, computed tomography, and ultrasound imaging in diagnosis of NAFLD is low; hence, Fibroscan was introduced . This is a non-invasive, simple-to-perform imaging modality with high accuracy to assess liver stiffness and hepatic fat deposition. Non-invasive diagnosis is based on clinical and biochemical markers, scoring models, and algorithms of methods which have sufficient sensitivity, specificity, and reproducibility . ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03625284 -
Oral Dietary Fucoxanthin Rich Supplement for Liver Health
|
N/A | |
| Completed |
NCT02923804 -
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
|
N/A | |
| Completed |
NCT03222206 -
The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease
|
Phase 4 | |
| Completed |
NCT04823676 -
Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management
|
N/A | |
| Completed |
NCT03186859 -
Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease)
|
N/A | |
| Completed |
NCT02030977 -
The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT06176079 -
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
|
||
| Not yet recruiting |
NCT06138821 -
ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial
|
Phase 4 | |
| Not yet recruiting |
NCT03801577 -
Hepaxa Management of Non-alcoholic Fatty Liver Disease
|
N/A | |
| Completed |
NCT05804422 -
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Adults NAFLD Patients (DELI_NAFLD Study)
|
N/A | |
| Recruiting |
NCT04625166 -
Combi-elastography Assessment of Chronic Liver Disease Multi-center Study
|
||
| Recruiting |
NCT05523024 -
Effect of Probiotics or Berberine in Hepatic Steatosis Markers, Cardiometabolic and Microbiotic Profile in NAFL.
|
N/A | |
| Not yet recruiting |
NCT05822622 -
Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.
|